|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02219 CHAOJU EYE CARE
Nominal 
2.940 +0.020 (+0.685%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,369,505 | 38.328% | 990,044 | 997,787 | 794,282 | 714,671 |
| Cost of Sales | (748,371) | 34.757% | (555,347) | (549,113) | (444,762) | (436,630) |
| Gross Profit | 621,134 | 42.889% | 434,697 | 448,674 | 349,520 | 278,041 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,835) | 47.460% | (3,957) | (13,608) | (12,165) | (17,279) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (1,496) | |
| Profit / (Loss) before Taxation | 299,242 | 25.134% | 239,138 | 210,582 | 157,621 | 92,064 | |
| Taxation | (78,507) | 40.336% | (55,942) | (52,941) | (37,090) | (21,240) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 8,179 | 79.522% | 4,556 | 4,108 | 3,608 | 4,827 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 228,914 | 21.924% | 187,752 | 161,749 | 124,139 | 75,651 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (29,085) | 162.571% | (11,077) | 2,218 | 8,152 | 16,162 |
| Depreciation & Amortisation | 123,361 | 24.148% | 99,366 | 83,522 | 77,251 | 76,240 |
| Directors' Emoluments | 6,013 | 39.093% | 4,323 | 5,161 | 3,242 | 4,613 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 33.000 | 22.222% | 27.000 | 26.000 | 23.000 | -- |
| DPS (cts) | 26.984 | -- | 15.227 | 8.478 | -- | -- |
| Dividend Payout Ratio (%) | 81.770% | -- | 56.396% | 32.609% | -- | -- |
| Cash flow per share ($) | 0.536 | -- | 0.387 | 0.399 | 0.452 | -- |
| NBV per share ($) | 3.335 | -- | 3.212 | 2.976 | -- | -- |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 136,453,000 |
| %Change | -9.402% |
| EPS / (LPS) | RMB 0.200 |
| NBV Per Share (¥) | RMB 3.286 |